Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction (BAMI)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Queen Mary University of London
Information provided by (Responsible Party):
Anthony Mathur, Barts & The London NHS Trust Identifier:
First received: March 30, 2012
Last updated: June 10, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2018
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)